MedPath

Influences of Multivitamin Supplementation on Health Parameters

Not Applicable
Completed
Conditions
Health Behavior
Interventions
Dietary Supplement: Placebo
Dietary Supplement: multivitamin supplement
Registration Number
NCT03071796
Lead Sponsor
Martin-Luther-Universität Halle-Wittenberg
Brief Summary

In this study the investigator will evaluate whether a liquid multivitamin supplement influences blood and vital parameters. Furthermore the investigator will establish the effects on life quality, mood and perception of stress and will characterize changes on immune system.

Detailed Description

The double-blind, randomized intervention study is conducted for 12 weeks and includes two groups (placebo versus verum) with same number of participants.

The investigator aims to determine the effects of multivitamin supplement on blood and vital parameters which includes blood pressure, pulse, heart rate, variability of heart rate, vitamin D, vitamin B12, folic acid, homocysteine, HbA1c. Furthermore the investigator will access life quality, mood and perception of stress through the following questionnaire POMS, PSS-10, SF12 \& SF36. The investigator will evaluate whether the multivitamin supplement changes the frequency of diseases like cold which represents the function of the immune system.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • healthy women and men
  • age between 30-60 years
  • employed
Read More
Exclusion Criteria
  • acute and chronic diseases (including diabetes, inflammatory bowel diseases, dementia, multiple sclerosis)
  • frequent use of alcohol, drugs or cigarettes (>5 cigarettes / day)
  • use of additional supplements
  • use of medications (e.g. antihypertensive medications, lipid reducers, thyroid medication)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboPlaceboliquids with similar appearance and taste like multivitamin supplement for 12 weeks
multivitamin supplementmultivitamin supplementliquid multivitamin supplement for 12 weeks
Primary Outcome Measures
NameTimeMethod
Plasma concentration of Vitamin B12change measures (baseline to 12 weeks)

vitamin B12 \[pmol/l\]

Secondary Outcome Measures
NameTimeMethod
Analysis of blood pressurechange measures (baseline to 12 weeks)

blood pressure

Analysis of heart rate variabilitychange measures (baseline to 12 weeks)

heart rate variability

Analysis of speed of pulse wave,change measures (baseline to 12 weeks)

speed of pulse wave

Plasma concentration of 25-hydroxyvitamin Dchange measures (baseline to 12 weeks)

25-hydroxyvitamin D \[nmol/l\]

Plasma concentration of folic acidchange measures (baseline to 12 weeks)

folic acid \[nmol/l\]

Plasma concentration of homocysteinechange measures (baseline to 12 weeks)

homocysteine \[µmol/l\]

Plasma concentration of HbA1cchange measures (baseline to 12 weeks)

HbA1c \[mmol\]

Trial Locations

Locations (1)

University of Halle-Wittenberg

🇩🇪

Halle (Saale), Germany

© Copyright 2025. All Rights Reserved by MedPath